Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Satoshi Mutoh"'
Autor:
Hiroaki Matsumoto, Koji Shiraishi, Haruhito Azuma, Keiji Inoue, Hirotsugu Uemura, Masatoshi Eto, Chikara Ohyama, Osamu Ogawa, Eiji Kikuchi, Hiroshi Kitamura, Nobuo Shinohara, Satoru Takahashi, Toyonori Tsuzuki, Masayuki Nakagawa, Yoshifumi Narumi, Hiroyuki Nishiyama, Tomonori Habuchi, Shiro Hinotsu, Yasuhisa Fujii, Kiyohide Fujimoto, Hiroyuki Fujimoto, Takashi Mizowaki, Hideyasu Matsuyama, Nobuyuki Sekita, Hiroshi Juri, Yuki Inada, Takashige Abe, Hideo Fukuhara, Yukio Naya, Satoshi Mutoh, Shigehisa Kitano, Takashi Kobayashi, Teruo Inamoto, Makito Miyake, Junichi Inokuchi, Tetsutaro Hayashi, Takahiro Kojima, Katsuyoshi Hashine, Toshiki Kijima, Yoshiyuki Matsui, Tomohiko Hara, Shingo Hatakeyama, Yoshiaki Yamamoto, Shintaro Narita, Tomoyasu Tsushima, Takafumi Miura, Takeru Shiroiwa, Mototsugu Oya, Momokazu Gotoh, Haruki Kume, Yasutomo Nasu, Katsuyuki Tsunemune
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationReferences. 27(5)
The Clinical Practice Guidelines for Bladder Cancer edited by the Japanese Urological Association were first published in 2009 and a revised edition was released in 2015. Four years has passed since the 2015 edition, and the clinical practice environ
Autor:
Yutaka Shio, Hiroshi Yaginuma, Takeo Hasegawa, Mika Hoshino, Takuya Inoue, Yuki Owada, Atsushi Yonechi, Mitsunori Higuchi, Mitsukazu Gotoh, Takumi Yamaura, Naoyuki Okabe, Satoshi Mutoh, Yuzuru Watanabe, Hiroyuki Suzuki, Jun Ohsugi, Mitsuro Fukuharav
Publikováno v:
Human vaccinesimmunotherapeutics. 10(2)
Despite of recent development in the field of molecular targeted therapies, lung cancer is a leading cause of cancer death in the world. Remarkable progress has been made recently in immunotherapy for patients with non-small-cell lung cancer (NSCLC),
Autor:
Hiroyuki Suzuki, Yuki Owada, Yuzuru Watanabe, Takuya Inoue, Mitsuro Fukuharav, Takumi Yamaura, Satoshi Mutoh, Naoyuki Okabe, Hiroshi Yaginuma, Takeo Hasegawa, Atsushi Yonechi, Jun Ohsugi, Mika Hoshino, Mitsunori Higuchi, Yutaka Shio, Mitsukazu Gotoh
Publikováno v:
Human Vaccines & Immunotherapeutics; Feb2014, Vol. 10 Issue 2, p1-6, 6p
Publikováno v:
Doboku Gakkai Ronbunshu. 1987:65-74
Publikováno v:
Chemical and Pharmaceutical Bulletin. 28:3696-3698
A new polyacrylamide gel electrophoretic system with post-labeling of proteins with o-phthalaldehyde (OPT) has been developed. In the present system, the widely used tris, glycine and ammonium persulfate were replaced by triethanolamine, L-hydroxypro
Autor:
Kazuyoshi Takeda, Atsushi Yonechi, Mika Hoshino, Takeo Hasegawa, Naoyuki Okabe, Kazuya Ise, Hiroyuki Suzuki, Takashi Kimura, Mitsukazu Gotoh, Takumi Yamaura, Hiroshi Yaginuma, Mitsunori Higuchi, Yutaka Shio, Mitsuro Fukuhara, Jun Osugi, Satoshi Mutoh
Publikováno v:
Journal of Translational Medicine
Vaccine treatment using multiple peptides derived from multiple proteins is considered to be a promising option for cancer immune therapy, but scientific evidence supporting the therapeutic efficacy of multiple peptides is limited. We conducted phase